Shannon Heaning, Content Associate

From emerging therapies to earlier intervention and psychosocial support, Dermatology Times looks back at key alopecia areata developments in 2026.

Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.

Dermatology Times and NPPA Connect celebrate National APP Week 2026 by highlighting the voices, experiences, and impact of advanced practice providers in dermatology.

Guselkumab met primary and major secondary endpoints in the phase 4 STAR study, improving axial PsA symptoms and MRI-confirmed inflammation.

Lauren Miller, PA-C, reflects on nearly 20 years in dermatology and how the PA profession has allowed her to grow as a clinician, educator, author, and mentor.

Donna Lam Cahill, PA-C, discusses her path to dermatology, patient advocacy, career persistence, and the evolving role of PAs during National APP Week.

Alexandra Charrow, MD, discussed biologic selection, deroofing, and emerging procedural approaches to hidradenitis suppurativa at Maui Derm NP+PA Fall 2026.

Week 28 data from the phase 2a EVERLAST-A trial showed PASI 100 responses increased to 71.4% despite no additional ORKA-001 dosing after week 4.

Immunovant will discontinue development of imeroprubart in cutaneous lupus erythematosus after the phase 2b study failed to meet its primary endpoint.

This review of the latest dermatological studies includes insights on

Jamie Nichole Restivo, MPAS, PA-C, reflects on her path to dermatology, the evolving role of APPs, and the power of collaboration during National APP Week.

For Alopecia Awareness Month, Deann of Alopecia Life discusses compassion, treatment expectations, and the psychosocial burden of alopecia areata.

The designation marks the first FDA Fast Track status granted to a therapy for peeling skin syndrome, which currently has no approved treatment.

Test your knowledge of the hidden costs, financial metrics, and operational decisions that can shape a dermatology practice.

Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.

Justin Love, MPAS, PA-C, highlights the financial considerations that can shape the long-term health of a dermatology practice.

Maui Derm NP+PA Fall 2026 brought APPs together for updates spanning inflammatory disease, oncology, emerging therapies, and diagnostic challenges.

Dermatology Times previews the research, clinical updates, late-breaking data, and therapeutic advances to watch at EADV 2026 in Vienna.

NPPA Connect celebrates National APP Week by recognizing the NPs and PAs helping shape the future of dermatologic care.

Day 2 explored infectious disease, challenging diagnoses, GLP-1s in psoriasis, and evolving approaches to inflammatory skin disease.

From prevention and early detection to immunotherapy and radiation, revisit key takeaways from the Cutaneous Oncology Workshop.

Stay ahead with a weekly roundup of the biggest practice management, AI, policy, business, and professional development updates in dermatology.

Day 1 of Maui Derm NP+PA Fall 2026 highlighted emerging therapies, cutaneous oncology, challenging dermatitis cases, and procedural pearls.

Chantel Hillstead, a board-certified dermatology nurse practitioner, discussed how patients with hidradenitis suppurativa can prepare for unpredictable flares.

Maui Derm NP+PA Fall 2026 brings dermatology NPs and PAs together for clinical updates, interactive cases, and practical treatment discussions.

A seemingly benign pigmented lesion reveals a more complex diagnosis after deeper evaluation and molecular testing

Two small clinical studies evaluated skincare and dermabrasion for changes in skin quality among individuals taking medical weight loss medications.

Two-year POETYK PsA-2 data showed sustained ACR and minimal disease activity responses with deucravacitinib and no new safety signals.

Faculty from the Cutaneous Oncology Workshop answer practical questions spanning skin cancer prevention, diagnosis, treatment, and follow-up.